The global blood screening market is anticipated to grow at a CAGR of 6.9% during the forecast period (2021-2027). The rising prevalence of COVID-19 cases, rising testing for the disease, increasing awareness for the treatment, and rising FDA approvals, are driving the blood screening market during the forecast period. According to the Worldometers, as of 10th May 2021, around 159 million COVID-19 cases were reported that have been tested positive. In March 2020, Becton, Dickson, and Co., a medical technology company, and BioMedomics, a North Carolina-based clinical diagnosis company, had launched the FDA-approved point-of-care test to detect antibodies in blood to confirm that the current or past exposure of COVID-19 in 15 minutes.
Browse the full report description of "Global Blood Screening Market Size, Share & Trends Analysis Report by Screening Technology (Nucleic Acid Amplification Test, Western Blotting, Enzyme-Linked Immunosorbent Assay, and PCR-RNA), By Products (Testing Instruments, and Reagents & Kits), By End-users (Blood Banks, Hospitals, and Laboratories) Forecast, 2021-2027" at https://www.omrglobal.com/industry-reports/blood-screening-market
In July 2020, Becton, Dickinson, and Co. had announced that the US FDA approved an Emergency Usage Authorization for a rapid, point-of-care SARS-CoV-2 diagnostic test for use with the BD VeritorTM Plus System, which is widely available. The introduction of this new assay, which provides results in 15 minutes on a simple-to-use, highly portable instrument, is vital for increasing access to COVID-19 diagnostics owing to it allows for real-time results and decision-making while the patient is still in the hospital. Apart from it, in February 2021, Siemens Healthcare GmbH had announced that the laboratory test for the SARV-CoV-2 Antigen assay of the company got a CE mark and has submitted the test to the US FDA for emergency use authorization (EUA). Thus, the various technological advancements in the tests by key players, rising FDA approvals to detect antibodies in the blood, new blood screening devices, and among others, are the factors that are driving the growth of the market during the forecast period.
Market Coverage
o By Screening Technology
o By Products
o By End-Users
o North America
o Europe
o Asia-Pacific
o Rest of the World
Recent Activities by the Key Players in Global Blood Screening Market
Key questions addressed by the report
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
Global Blood Screening Market Report Segment
By Screening Technology
By Products
By End-Users
Global Blood Screening Market Report Segment by Region
North America
Europe
Asia-Pacific
Rest of the World
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/blood-screening-market